Insulin resistance in microvascular angina (syndrome X) 1993

H E Bøtker, and N Møller, and P Ovesen, and A Mengel, and O Schmitz, and H Orskov, and J P Bagger
Department of Cardiology, Skejby Hospital, University Hospital, Aarhus, Denmark.

Patients with microvascular angina (syndrome X) may be insulin resistant. We designed a study to establish whether this is the case. 11 patients with microvascular angina were compared with 9 matched subjects with noncardiac chest pain. Patients and controls were evaluated by coronary sinus catheterisation, and by isotopic measurement of glucose turnover, indirect calorimetry, and forearm technique during a 3 h baseline period after overnight fast and during a 2 h hyperinsulinaemic euglycaemic clamp. Pace-induced increase in coronary sinus blood flow was less in patients than in controls, whereas forearm blood flow did not differ between groups. Baseline measures of glucose metabolism were normal. During the clamp, glucose production and lipolysis were equally suppressed in both groups. Mean (SE) total insulin-induced glucose uptake was significantly impaired in patients compared with controls (3.9 [0.7] vs 6.4 [0.7] mg/kg per min; p < 0.01), and insulin-stimulated glucose uptake in the forearm was significantly reduced in patients (0.88 [0.10] vs 1.6 [0.30] mmol/L; p < 0.001). Reduced oxidative and nonoxidative metabolism accounted for the defect in overall glucose uptake in patients. No correlation between changes in coronary sinus blood flow and total body glucose uptake was seen. We found that microvascular angina was associated with substantial insulin resistance. Whether this relation is causal or coincidental is as yet unsettled.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D002637 Chest Pain Pressure, burning, or numbness in the chest. Precordial Catch,Precordial Catch Syndrome,Texidor's Twinge,Chest Pains,Pain, Chest,Pains, Chest,Syndrome, Precordial Catch,Texidor Twinge

Related Publications

H E Bøtker, and N Møller, and P Ovesen, and A Mengel, and O Schmitz, and H Orskov, and J P Bagger
March 1995, Zeitschrift fur Kardiologie,
H E Bøtker, and N Møller, and P Ovesen, and A Mengel, and O Schmitz, and H Orskov, and J P Bagger
January 2002, Revista espanola de cardiologia,
H E Bøtker, and N Møller, and P Ovesen, and A Mengel, and O Schmitz, and H Orskov, and J P Bagger
June 1998, Minerva cardioangiologica,
H E Bøtker, and N Møller, and P Ovesen, and A Mengel, and O Schmitz, and H Orskov, and J P Bagger
June 2000, European journal of clinical investigation,
H E Bøtker, and N Møller, and P Ovesen, and A Mengel, and O Schmitz, and H Orskov, and J P Bagger
July 1995, Metabolism: clinical and experimental,
H E Bøtker, and N Møller, and P Ovesen, and A Mengel, and O Schmitz, and H Orskov, and J P Bagger
February 1995, Vnitrni lekarstvi,
H E Bøtker, and N Møller, and P Ovesen, and A Mengel, and O Schmitz, and H Orskov, and J P Bagger
February 1991, Lancet (London, England),
H E Bøtker, and N Møller, and P Ovesen, and A Mengel, and O Schmitz, and H Orskov, and J P Bagger
January 2000, Zeitschrift fur Kardiologie,
H E Bøtker, and N Møller, and P Ovesen, and A Mengel, and O Schmitz, and H Orskov, and J P Bagger
January 1997, Deutsche medizinische Wochenschrift (1946),
H E Bøtker, and N Møller, and P Ovesen, and A Mengel, and O Schmitz, and H Orskov, and J P Bagger
May 1995, Journal of the American College of Cardiology,
Copied contents to your clipboard!